Gene expression modulation and the molecular mechanisms involved in Nelfinavir resistance in Leishmania donovani axenic amastigotes

Molecular Microbiology

Volumn 89, Issue 3, 2013, Pages 565-582

  Kumar, Pranav ^a   Lodge, Robert ^a   Raymond, Frédéric ^a   Ritt, Jean François ^a   Jalaguier, Pascal ^a   Corbeil, Jacques ^a,b   Ouellette, Marc ^a,b   Tremblay, Michel J ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; MESSENGER RNA; NELFINAVIR; POLYPHOSPHATE;

ACIDOCALCISOME; AMASTIGOTE; ANEUPLOIDY; ARTICLE; CELL COMPARTMENTALIZATION; CELL VACUOLE; CHROMOSOME 11; CHROMOSOME 6; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOPLASM; DRUG ACCUMULATION; DRUG RESISTANCE; DRUG SENSITIVITY; GENE CONTROL; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEISHMANIA DONOVANI; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANEUPLOIDY; CELLS, CULTURED; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; DRUG RESISTANCE; GENE EXPRESSION PROFILING; HUMANS; LEISHMANIA DONOVANI; MACROPHAGES; NELFINAVIR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, PROTOZOAN; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; LEISHMANIA DONOVANI;

EID: 84880831125     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/mmi.12298     Document Type: Article

References (68)

1. Akopyants, N.S., Kimblin, N., Secundino, N., Patrick, R., Peters, N., Lawyer, P., etal. (2009) Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector. Science 324: 265-268.
2. Alexander, J., and Russell, D.G. (1992) The interaction of Leishmania species with macrophages. Adv Parasitol 31: 175-254.
3. Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Canavate, C., Dedet, J.P., etal. (2008) The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334-359.
4. Aschar-Sobbi, R., Abramov, A.Y., Diao, C., Kargacin, M.E., Kargacin, G.J., French, R.J., etal. (2008) High sensitivity, quantitative measurements of polyphosphate using a new DAPI-based approach. J Fluoresc 18: 859-866.
5. Beverley, S.M. (1991) Gene amplification in Leishmania. Annu Rev Microbiol 45: 417-444.
6. Brazas, M.D., and Hancock, R.E. (2005) Using microarray gene signatures to elucidate mechanisms of antibiotic action and resistance. Drug Discov Today 10: 1245-1252.
7. Brochu, C., Haimeur, A., and Ouellette, M. (2004) The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite Leishmania. Cell Stress Chaperones 9: 294-303.
8. Carter, C.A., and Ehrlich, L.S. (2008) Cell biology of HIV-1 infection of macrophages. Annu Rev Microbiol 62: 425-443.
9. Chawla, B., Jhingran, A., Panigrahi, A., Stuart, K.D., and Madhubala, R. (2011) Paromomycin affects translation and vesicle-mediated trafficking as revealed by proteomics of paromomycin -susceptible -resistant Leishmania donovani. PLoS ONE 6: e26660.
10. Chow, L.M., Wong, A.K., Ullman, B., and Wirth, D.F. (1993) Cloning and functional analysis of an extrachromosomally amplified multidrug resistance-like gene in Leishmania enriettii. Mol Biochem Parasitol 60: 195-208.
11. Clayton, C.E. (2002) Life without transcriptional control? From fly to man and back again. EMBO J 21: 1881-1888.
12. Corrêa, A.F.S., Andrade, L.R., and Soares, M.J. (2002) Elemental composition of acidocalcisomes of Trypanosoma cruzi bloodstream trypomastigote forms. Parasitol Res 88: 875-880.
13. Deeks, S.G., Smith, M., Holodniy, M., and Kahn, J.O. (1997) HIV-1 protease inhibitors. A review for clinicians. JAMA 277: 145-153.
14. Docampo, R., and Moreno, S.N. (1999) Acidocalcisomes: a novel Ca2+ storage compartment in trypanosomatids and apicomplexan parasites. Parasitol Today 15: 443-448.
15. Dodge, M.A., Waller, R.F., Chow, L.M., Zaman, M.M., Cotton, L.M., McConville, M.J., etal. (2004) Localization and activity of multidrug resistance protein 1 in the secretory pathway of Leishmania parasites. Mol Microbiol 51: 1563-1575.
16. Downing, T., Imamura, H., Decuypere, S., Clark, T.G., Coombs, G.H., Cotton, J.A., etal. (2011) Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res 21: 2143-2156.
17. Ford, J., Khoo, S.H., and Back, D.J. (2004) The intracellular pharmacology of antiretroviral protease inhibitors. J Antimicrob Chemother 54: 982-990.
18. Garg, R., Barat, C., Ouellet, M., Lodge, R., and Tremblay, M.J. (2009) Leishmania infantum amastigotes enhance HIV-1 production in cocultures of human dendritic cells and CD4 T cells by inducing secretion of IL-6 and TNF-α. PLoS Negl Trop Dis 3: e441.
19. Genois, M.M., Mukherjee, A., Ubeda, J.M., Buisson, R., Paquet, E., Roy, G., etal. (2012) Interactions between BRCA2 and RAD51 for promoting homologous recombination in Leishmania infantum. Nucleic Acids Res 40: 6570-6584.
20. Grondin, K., Papadopoulou, B., and Ouellette, M. (1993) Homologous recombination between direct repeat sequences yields P-glycoprotein containing amplicons in arsenite resistant Leishmania. Nucleic Acids Res 21: 1895-1901.
21. Haimeur, A., Guimond, C., Pilote, S., Mukhopadhyay, R., Rosen, B.P., Poulin, R., and Ouellette, M. (1999) Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania. Mol Microbiol 34: 726-735.
22. Hartl, F.U., and Hayer-Hartl, M. (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295: 1852-1858.
23. Holzer, T.R., McMaster, W.R., and Forney, J.D. (2006) Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in Leishmania mexicana. Mol Biochem Parasitol 146: 198-218.
24. Ifergan, I., Scheffer, G.L., and Assaraf, Y.G. (2005) Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance. Cancer Res 65: 10952-10958.
25. Jones, K., Hoggard, P.G., Sales, S.D., Khoo, S., Davey, R., and Back, D.J. (2001) Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport. AIDS 15: 675-681.
26. Kramer, D.L., Black, J.D., Mett, H., Bergeron, R.J., and Porter, C.W. (1998) Lysosomal sequestration of polyamine analogues in Chinese hamster ovary cells resistant to the S-adenosylmethionine decarboxylase inhibitor, CGP-48664. Cancer Res 58: 3883-3890.
27. Kumar, P., Lodge, R., Trudel, N., Ouellet, M., Ouellette, M., and Tremblay, M.J. (2010) Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes. PLoS Negl Trop Dis 4: e642.
28. Légaré, D., Richard, D., Mukhopadhyay, R., Stierhof, Y.D., Rosen, B.P., Haimeur, A., etal. (2001) The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J Biol Chem 276: 26301-26307.
29. Leprohon, P., Légaré, D., Girard, I., Papadopoulou, B., and Ouellette, M. (2006) Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites. Eukaryot Cell 5: 1713-1725.
30. Leprohon, P., Légaré, D., Raymond, F., Madore, E., Hardiman, G., Corbeil, J., and Ouellette, M. (2009) Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum. Nucleic Acids Res 37: 1387-1399.
31. Lira, R., Sundar, S., Makharia, A., Kenney, R., Gam, A., Saraiva, E., and Sacks, D. (1999) Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis 180: 564-567.
32. Lodge, R., Ouellet, M., Barat, C., Andreani, G., Kumar, P., and Tremblay, M.J. (2012) HIV-1 promotes intake of Leishmania parasites by enhancing phosphatidylserine-mediated, CD91/LRP-1-dependent phagocytosis in human macrophages. PLoS ONE 7: e32761.
33. López-Martín, C., Pérez-Victoria, J.M., Carvalho, L., Castanys, S., and Gamarro, F. (2008) Sitamaquine sensitivity in Leishmania species is not mediated by drug accumulation in acidocalcisomes. Antimicrob Agents Chemother 52: 4030-4036.
34. Lopez-Velez, R. (2003) The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV. Ann Trop Med Parasitol 97 (Suppl. 1): 143-147.
35. Machuca, C., Rodriguez, A., Herrera, M., Silva, S., and Ponte-Sucre, A. (2006) Leishmania amazonensis: metabolic adaptations induced by resistance to an ABC transporter blocker. Exp Parasitol 114: 1-9.
36. Miller, M.A., McGowan, S.E., Gantt, K.R., Champion, M., Novick, S.L., Andersen, K.A., etal. (2000) Inducible resistance to oxidant stress in the protozoan Leishmania chagasi. J Biol Chem 275: 33883-33889.
37. do Monte-Neto, R.L., Coelho, A.C., Raymond, F., Légaré, D., Corbeil, J., Melo, M.N., etal. (2011) Gene expression profiling and molecular characterization of antimony resistance in Leishmania amazonensis. PLoS Negl Trop Dis 5: e1167.
38. Mookerjee Basu, J., Mookerjee, A., Banerjee, R., Saha, M., Singh, S., Naskar, K., etal. (2008) Inhibition of ABC transporters abolishes antimony resistance in Leishmania Infection. Antimicrob Agents Chemother 52: 1080-1093.
39. Ouellette, M., Hettema, E., Wust, D., Fase-Fowler, F., and Borst, P. (1991) Direct and inverted DNA repeats associated with P-glycoprotein gene amplification in drug resistant Leishmania. EMBO J 10: 1009-1016.
40. Ouellette, M., Drummelsmith, J., Leprohon, P., El Fadili, K., Foucher, A., Vergnes, B., and Légaré, D. (2007) Drug Resistance in Leishmania. Norwich: Horizon Press.
41. Perteguer, M.J., Gomez-Puertas, P., Canavate, C., Dagger, F., Garate, T., and Valdivieso, E. (2012) Ddi1-like protein from Leishmania major is an active aspartyl proteinase. Cell Stress Chaperones 18: 171-181.
42. Polakova, S., Blume, C., Zarate, J.A., Mentel, M., Jorck-Ramberg, D., Stenderup, J., and Piskur, J. (2009) Formation of new chromosomes as a virulence mechanism in yeast Candida glabrata. Proc Natl Acad Sci USA 106: 2688-2693.
43. Rancati, G., Pavelka, N., Fleharty, B., Noll, A., Trimble, R., Walton, K., etal. (2008) Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell 135: 879-893.
44. Rogers, M.B., Hilley, J.D., Dickens, N.J., Wilkes, J., Bates, P.A., Depledge, D.P., etal. (2011) Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res 21: 2129-2142.
45. de la Rosa, R., Pineda, J.A., Delgado, J., Macias, J., Morillas, F., Martin-Sanchez, J., etal. (2001) Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients. Clin Infect Dis 32: 633-635.
46. Rosenthal, E., Tempesta, S., Del Giudice, P., Marty, P., Desjeux, P., Pradier, C., etal. (2001) Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy. AIDS 15: 1184-1185.
47. Roy, G., Dumas, C., Sereno, D., Wu, Y., Singh, A.K., Tremblay, M.J., etal. (2000) Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol 110: 195-206.
48. Sambrook, J., Fritsch, F.E., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. New York: Cold Spring Harbour Laboratory Press.
49. Santos, L.O., Marinho, F.A., Altoe, E.F., Vitorio, B.S., Alves, C.R., Britto, C., etal. (2009) HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis. PLoS ONE 4: e4918.
50. Santos, L.O., Vitorio, B.S., Branquinha, M.H., Silva, C.M., Santos, A.L., and d'Avila-Levy, C.M. (2012) Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients. J Antimicrob Chemother 68: 348-353.
51. Savoia, D., Allice, T., and Tovo, P.A. (2005) Antileishmanial activity of HIV protease inhibitors. Int J Antimicrob Agents 26: 92-94.
52. Sereno, D., and Lemesre, J.L. (1997) Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chemother 41: 972-976.
53. Singh, R., Kumar, D., Duncan, R.C., Nakhasi, H.L., and Salotra, P. (2010) Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites. Int J Antimicrob Agents 36: 50-57.
54. Skinner-Adams, T.S., McCarthy, J.S., Gardiner, D.L., Hilton, P.M., and Andrews, K.T. (2004) Antiretrovirals as antimalarial agents. J Infect Dis 190: 1998-2000.
55. Smyth, G.K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
56. Smyth, G.K., and Speed, T. (2003) Normalization of cDNA microarray data. Methods 31: 265-273.
57. Smyth, G.K., Michaud, J., and Scott, H.S. (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21: 2067-2075.
58. Sognier, M.A., Zhang, Y., Eberle, R.L., Sweet, K.M., Altenberg, G.A., and Belli, J.A. (1994) Sequestration of doxorubicin in vesicles in a multidrug-resistant cell line (LZ-100). Biochem Pharmacol 48: 391-401.
59. Sterkers, Y., Lachaud, L., Crobu, L., Bastien, P., and Pages, M. (2010) FISH analysis reveals aneuploidy and continual generation of chromosomal mosaicism in Leishmania major. Cell Microbiol 13: 274-283.
60. Torres, C., Perez-Victoria, F.J., Parodi-Talice, A., Castanys, S., and Gamarro, F. (2004) Characterization of an ABCA-like transporter involved in vesicular trafficking in the protozoan parasite Trypanosoma cruzi. Mol Microbiol 54: 632-646.
61. Trudel, N., Garg, R., Messier, N., Sundar, S., Ouellette, M., and Tremblay, M.J. (2008) Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors. J Infect Dis 198: 1292-1299.
62. Ubeda, J.M., Légaré, D., Raymond, F., Ouameur, A.A., Boisvert, S., Rigault, P., etal. (2008) Modulation of gene expression in drug resistant Leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy. Genome Biol 9: R115.
63. Vergnes, B., Gourbal, B., Girard, I., Sundar, S., Drummelsmith, J., and Ouellette, M. (2007) A proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death. Mol Cell Proteomics 6: 88-101.
64. White, R.E., Powell, D.J., and Berry, C. (2011) HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites. FASEB J 25: 1729-1736.
65. Wilson, M., DeRisi, J., Kristensen, H.H., Imboden, P., Rane, S., Brown, P.O., and Schoolnik, G.K. (1999) Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. Proc Natl Acad Sci USA 96: 12833-12838.
66. Yang, Y., Hoh, J., Broger, C., Neeb, M., Edington, J., Lindpaintner, K., and Ott, J. (2003) Statistical methods for analyzing microarray feature data with replications. J Comput Biol 10: 157-169.
67. Zhao, C., Papadopoulou, B., and Tremblay, M.J. (2004) Leishmania infantum promotes replication of HIV type 1 in human lymphoid tissue cultured ex vivo by inducing secretion of the proinflammatory cytokines TNF-α and IL-1α. J Immunol 172: 3086-3093.
68. Zhao, C., Thibault, S., Messier, N., Ouellette, M., Papadopoulou, B., and Tremblay, M.J. (2006) In primary human monocyte-derived macrophages exposed to Human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake? J Gen Virol 87: 1295-1302.